Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Nov-23 4:19 PM View:  | Mallinckrodt plc (MNKTQ) | 14-Nov-23 | Disposition | 189,863 | -- | -- | (100%) 189.86K to 0 | |
| 26-Jun-23 7:54 PM View: | Mallinckrodt plc (MNKTQ) | 23-Jun-23 | Payment of Exercise | 38,409 | $1.31 | $50,315.80 | (17%) 228.27K to 189.86K | |
| 15-Mar-23 2:08 PM View: | Mallinckrodt plc (MNKTQ) | 13-Mar-23 | Private Purchase | 3,000 | $8.37 | $25,121.40 | 1% 225.27K to 228.27K | |
| 22-Dec-22 5:45 PM View: | Mallinckrodt plc (MNKTQ) | 14-Dec-22 | Grant | 225,272 | -- | -- | 100% 0 to 225.27K | |
| 13-Nov-13 8:19 PM View: | Allergan Plc (AGN) | 11-Nov-13 | Market Sale | 25,000 | $159.87 | $3,996,750.00 | (26%) 96.95K to 71.95K | 9% |
| 02-Oct-13 9:13 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 96,947 | -- | -- | (100%) 96.95K to 0 | |
| 03-Oct-13 4:30 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 96,947 | -- | -- | 100% 0 to 96.95K | |
| 02-Oct-13 9:13 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Grant | 44,149 | -- | -- | 52% 84.64K to 128.79K | |
| 02-Oct-13 9:13 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Payment of Exercise | 181,845 | $144.00 | $26,185,700.00 | (65%) 278.79K to 96.95K | 83% |
| 02-Oct-13 9:13 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Option Exercise | 150,000 | $86.86 | $13,029,000.00 | 116% 128.79K to 278.79K | |
| 06-Aug-13 3:58 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Aug-13 | Payment of Exercise | 4,500 | $135.47 | $609,597.00 | (5%) 89.14K to 84.64K | 82% |
| 10-Apr-13 7:06 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Apr-13 | Acquisition (other) | 8,163 | -- | -- | 10% 80.98K to 89.14K | |
| 08-Mar-13 6:23 PM View: | Watson Pharmaceuticals Inc. (ACT) | 06-Mar-13 | Grant | 16,519 | -- | -- | 26% 64.46K to 80.98K | |
| 05-Mar-13 7:22 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-13 | Payment of Exercise | 3,702 | $85.54 | $316,669.00 | (5%) 68.16K to 64.46K | 72% |
| 02-Nov-12 12:42 PM View: | Watson Pharmaceuticals Inc. (ACT) | 31-Oct-12 | Grant | 14,543 | -- | -- | 27% 53.62K to 68.16K | |
| 05-Sep-12 1:02 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Sep-12 | Payment of Exercise | 811 | $81.35 | $65,974.90 | (1%) 54.43K to 53.62K | 70% |
| 12-Mar-12 2:29 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Mar-12 | Grant | 18,580 | -- | -- | 52% 35.85K to 54.43K | |
| 04-Mar-11 4:47 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-11 | Grant | 10,851 | -- | -- | 43% 25.0K to 35.85K | |
| 02-Sep-10 5:27 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Sep-10 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K |